Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis

Completed · Not applicable · Has a placebo group

Conditions studied: Cystic Fibrosis, Anemia, Iron-Deficiency

In brief

This study questions whether low-dose ferrous sulfate taken by mouth daily for 6 weeks increases hemoglobin concentration in adult subjects with cystic fibrosis and hypoferremic anemia.

Key facts

Study ID

NCT01755455

Run by

Dartmouth-Hitchcock Medical Center

People needed

22

Starts

2011-06-01

Expected to finish

2012-11-01

Last updated by the study team

2017-03-16

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of Pseudomonas aeruginosa colonization of the lung
• Transferrin saturation (TSAT) less than or equal to 21%
• Hemoglobin concentration <15.5 gm/dl (men)
• Hemoglobin concentration <13.6 gm/dl (women)

You may not qualify if…

• Use of iron-containing vitamin or supplement
• Pregnancy
• Lactation
• Cirrhosis
• History of chronic visible (gross) hemoptysis
• Hereditary hemochromatosis
• History of transfusion-related iron overload
• Use of iron chelator(s)
• Withdrawal of informed consent
• Contraindication to phlebotomy

Where it is running

• Maine Medical Center — Portland, Maine, United States
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.